Correction to: Health-Related Quality-of-Life Outcomes of Very Preterm or Very Low Birth Weight Adults: Evidence From an Individual Participant Data Meta-Analysis (PharmacoEconomics, (2023), 41, 1, (93-105), 10.1007/s40273-022-01201-2)

In Table 1 of this article, the column header “NZ-VLBW (New Zealand)” was incorrectly placed above the column titled “SF-6D at 19 years” but should have been placed above the columns titled “SF-6D at 22-23 years” and “SF-6D at 26-30 years”. Consequently, the column header “NTNU (Norway)” should have been placed above the columns titled “SF-6D at 19 years” and “SF-6D at 23 years”. The old incorrect and the correct versions of Table 1 are given below. Background characteristics of cohorts BLS (Germany) VICS (Australia) EPICure (UK and Ireland) NZ-VLBW (New Zealand) NTNU (Norway) HUI3 at 26 years SF-6D at 26 years HUI3 at 18 years SF-6D at 18 years HUI3 at 19 years SF-6D at 22–23 years SF-6D at 26–30 years SF-6D at 19 years SF-6D at 23 years VP/VLBW Controls VP/VLBW Controls EP/ELBW Controls EP/ELBW Controls EP Controls VP/VLBW Controls VP/VLBW Controls VP/VLBW Controls VP/VLBW Controls Number completing MAUI 231 224 231 226 186 137 180 143 110 62 230 68 243 100 52 73 33 35 Age at assessment, mean (SD) 26.3 (0.7) 26.3 (0.7) 26.3 (0.7) 26.3 (0.7) 17.9 (0.8) 18.0 (0.9) 18.0 (0.8) 18.1 (0.9) 19.3 (0.6) 19.2 (0.5) 23.4 (0.5) 23.7 (0.6) 28.5 (1.1) 28.3 (0.9) 19.7 (0.8) 19.7 (0.6) 22.5 (0.0) 22.7 (0.6) GA at birth, mean (SD) 30.6 (2.2) 39.7 (1.3) 30.6 (2.2) 39.7 (1.2) 26.7 (2.1) 39.2 (1.4) 26.7 (2.1) 39.2 (1.4) 24.5 (0.7) N/A 29.19 (2.5) N/A 29.20 (2.5) N/A 29.12 (2.4) 39.74 (1.2) 28.82 (2.7) 39.46 (1.1) Birth weight, mean (SD) 1330.1 (319.5) 3360.0 (447.9) 1329.7 (319.4) 3362.3 (446.8) 886.7 (155.3) 3419.1 (468.0) 885.7 (155.1) 3421.5 (462.5) 745.9 (119.4) N/A 1145.4 (238.4) N/A 1134.5 (235.8) N/A 1243.4 (202.8) 3718.9 (478.0) 1194.9 (254.7) 3610.6 (365.0) Male sex, N (%) 125 (54.1) 105 (46.9) 124 (53.7) 105 (46.5) 84 (45.2) 60 (43.8) 82 (45.6) 60 (42.0) 51 (46.4) 23 (37.1) 104 (45.2) 33 (48.5) 103 (42.4) 37 (37.0) 22 (42.3) 30 (41.1) 13 (39.4) 15 (42.9) Study name Bavarian Longitudinal Study Victorian Infant Collaborative Study EPICure New Zealand Very Low Birth Weight Norwegian University of Science and Technology Birth year 1985–6 1991–2 1995 1986 1986–8 Eligibility criteria VP/VLBW (GA <32 wk or BW <1500 g) EP/ELBW (GA <28 wk or BW <1000 g) EP (GA <26 wk) VLBW <1500 g VLBW <1500g Controls Recruited in the same obstetric hospitals Normal birth weight, contemporaneously recruited Recruited at school age Age matched Born to mothers of a 10% random sample, contemporaneously recruited BW body weight, GA gestational age, ELBW extremely low birth weight (<1000 g), EP extremely preterm (<26 wk GA for EPICure and <28 wk GA for VICS), HUI3 Health Utilities Index Mark 3, MAUI multi-attribute utility instrument, N/A not applicable/measurement not administered, SD standard deviation, SF-6D Short Form 6D, VLBW very low birth weight (<1500 g), VP very preterm (<32 wk GA), wk weeks Additional details for each study can be found in published research as follows: BLS [46], VICS [47], NTNU LBW Life [50], EPICure [48] and NZ-VLBW [49] Background characteristics of cohorts BLS (Germany) VICS (Australia) EPICure (UK and Ireland) NZ-VLBW (New Zealand) NTNU (Norway) HUI3 at 26 years SF-6D at 26 years HUI3 at 18 years SF-6D at 18 years HUI3 at 19 years SF-6D at 22–23 years SF-6D at 26–30 years SF-6D at 19 years SF-6D at 23 years VP/VLBW Controls VP/VLBW Controls EP/ELBW Controls EP/ELBW Controls EP Controls VP/VLBW Controls VP/VLBW Controls VP/VLBW Controls VP/VLBW Controls Number completing MAUI 231 224 231 226 186 137 180 143 110 62 230 68 243 100 52 73 33 35 Age at assessment, mean (SD) 26.3 (0.7) 26.3 (0.7) 26.3 (0.7) 26.3 (0.7) 17.9 (0.8) 18.0 (0.9) 18.0 (0.8) 18.1 (0.9) 19.3 (0.6) 19.2 (0.5) 23.4 (0.5) 23.7 (0.6) 28.5 (1.1) 28.3 (0.9) 19.7 (0.8) 19.7 (0.6) 22.5 (0.0) 22.7 (0.6) GA at birth, mean (SD) 30.6 (2.2) 39.7 (1.3) 30.6 (2.2) 39.7 (1.2) 26.7 (2.1) 39.2 (1.4) 26.7 (2.1) 39.2 (1.4) 24.5 (0.7) N/A 29.19 (2.5) N/A 29.20 (2.5) N/A 29.12 (2.4) 39.74 (1.2) 28.82 (2.7) 39.46 (1.1) Birth weight, mean (SD) 1330.1 (319.5) 3360.0 (447.9) 1329.7 (319.4) 3362.3 (446.8) 886.7 (155.3) 3419.1 (468.0) 885.7 (155.1) 3421.5 (462.5) 745.9 (119.4) N/A 1145.4 (238.4) N/A 1134.5 (235.8) N/A 1243.4 (202.8) 3718.9 (478.0) 1194.9 (254.7) 3610.6 (365.0) Male sex, N (%) 125 (54.1) 105 (46.9) 124 (53.7) 105 (46.5) 84 (45.2) 60 (43.8) 82 (45.6) 60 (42.0) 51 (46.4) 23 (37.1) 104 (45.2) 33 (48.5) 103 (42.4) 37 (37.0) 22 (42.3) 30 (41.1) 13 (39.4) 15 (42.9) Study name Bavarian Longitudinal Study Victorian Infant Collaborative Study EPICure New Zealand Very Low Birth Weight Norwegian University of Science and Technology Birth year 1985–6 1991–2 1995 1986 1986–8 Eligibility criteria VP/VLBW (GA <32 wk or BW <1500 g) EP/ELBW (GA <28 wk or BW <1000 g) EP (GA <26 wk) VLBW <1500 g VLBW <1500g Controls Recruited in the same obstetric hospitals Normal birth weight, contemporaneously recruited Recruited at school age Age matched Born to mothers of a 10% random sample, contemporaneously recruited BW body weight, GA gestational age, ELBW extremely low birth weight (<1000 g), EP extremely preterm (<26 wk GA for EPICure and <28 wk GA for VICS), HUI3 Health Utilities Index Mark 3, MAUI multi-attribute utility instrument, N/A not applicable/measurement not administered, SD standard deviation, SF-6D Short Form 6D, VLBW very low birth weight (<1500 g), VP very preterm (<32 wk GA), wk weeks Additional details for each study can be found in published research as follows: BLS [46], VICS [47], NTNU LBW Life [50], EPICure [48] and NZ-VLBW [49] The original article has been corrected.